3R7-30776-26185
5 vaccinations
8 coded responses
20 check-ins
8 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 201 / VA
- Registered
- 2021-03-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-09
Dose 1 — Moderna
-
2021-03-10
Registered in v-safe
-
2021-03-10
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Itching · Fever · Chills, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-16
Survey response — day 7, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-24
- 2021-03-30
-
2021-04-06
Dose 2 — Moderna
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
-
2021-04-22
Survey response — day 14, dose 2MedDRA: Asthenia, Headache, Nausea — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Headache, nausea, no energyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Report sent to call center — day 14, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-27
Survey response — day 21, dose 2MedDRA: Fatigue, Headache, Nausea, Vision blurred — Feeling: Fair · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Tired, headache, nauseous, blurry visionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-27
Report sent to call center — day 21, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-04
Survey response — day 28, dose 2MedDRA: Fatigue, Headache, Hypoaesthesia, Muscular weakness, Vision blurred — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Headache, blurry vision, extreme fatigue and arm/leg weakness and numbnessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-12
Survey response — day 35, dose 2MedDRA: Headache, Hypoaesthesia, Nausea, Paraesthesia, Vision blurred, Vomiting — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: Nausea, vomiting, headache, blurry vision, numbness and tingling in arms and legsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-18
-
2021-09-14
Dose 3 — Moderna
-
2021-10-06
Survey response — 6 months, dose 2MedDRA: Asthenia, Fatigue, Office visit, Oxygen saturation decreased, Vision blurred — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Oxygen level drops during sleep, vision blurry, tired and no energy. · Healthcare visit (other): Visits to Primary Care, Transplant team, Pulmonologist and Infectious DiseaseMedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-10-07
Call successfulParticipant prefers to complete VAERS report online
- 2021-10-29
- 2021-12-14
-
2022-03-15
Survey response — 6 months, dose 3MedDRA: Cardiac failure congestive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Diagnosed with CHFMedDRA releases: 2024-11 · check-in free text available
-
2022-03-15
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
-
2022-03-17
Call successfulParticipant prefers to complete VAERS report online
-
2022-03-23
Dose 4 — Moderna
-
2022-09-29
Dose 5 — Pfizer-BioNTechCo-administered: Shingles:Tetanus
-
2022-10-08
Survey response — day 7, dose 5MedDRA: Lethargy, Pain in extremity, Pyrexia — Feeling: GoodFree text: I did have low grade fever, pain in both arms (3 shots in one day) and was very lethargic for 3 days starting Sept 30th. I am fine now.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-09 | Moderna | |
| 2 | 2021-04-06 | Moderna | |
| 3 | 2021-09-14 | Moderna | No |
| 4 | 2022-03-23 | Moderna | No |
| 5 | 2022-09-29 | Pfizer-BioNTech | Shingles:Tetanus |
Call center
4 call center cases
4 successful
Free text
Release 5 — day 7, dose 1
Systemic reaction (other): No
Release 7 — day 14, dose 2
Symptoms: Headache, nausea, no energy
Release 8 — day 21, dose 2
Symptoms: Tired, headache, nauseous, blurry vision
Release 8 — day 28, dose 2
Symptoms: Headache, blurry vision, extreme fatigue and arm/leg weakness and numbness
Release 8 — day 35, dose 2
Symptoms: Nausea, vomiting, headache, blurry vision, numbness and tingling in arms and legs
Release 10 — 6 months, dose 2
Symptoms: Oxygen level drops during sleep, vision blurry, tired and no energy.
Healthcare visit (other): Visits to Primary Care, Transplant team, Pulmonologist and Infectious Disease
Release 11 — 6 months, dose 3
Symptoms: Diagnosed with CHF
Release 12 — day 7, dose 5
Systemic reaction (other): I did have low grade fever, pain in both arms (3 shots in one day) and was very lethargic for 3 days starting Sept 30th. I am fine now.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Asthenia | ✓ | ✓ | ✓ |
| SD | Cardiac failure congestive | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypoaesthesia | ✓ | ✓ | ✓ |
| SD | Muscular weakness | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Oxygen saturation decreased | · | · | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SD | Vision blurred | ✓ | ✓ | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
| SRO | Lethargy | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | · | · | ✓ |
| SRO | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release